UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Durvalumab in frail and elder patients with stage four NSCLC: The DURATION trial

Annals of oncology, 2018-10, Vol.29, p.viii546-viii547

2018

Volltextzugriff (PDF)

Focal species and landscape “naturalness” corridor models offer complementary approaches for connectivity conservation planning

Landscape ecology, 2015-12, Vol.30 (10), p.2121-2132

2015

Volltextzugriff (PDF)

1890P Switch-maintenance therapy with nivolumab in TKI-sensitive patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis for PD-L1 status of a randomized phase II study (NIVOSWITCH)

Annals of oncology, 2023-10, Vol.34, p.S1017-S1017

2023

Volltextzugriff (PDF)

1293MO Safety and efficacy of hypo- and conventionally fractionated thoracic radiotherapy plus durvalumab in elderly or frail NSCLC stage III patients unfit for chemotherapy: Interim results from the TRADE-hypo trial

Annals of oncology, 2023-10, Vol.34, p.S746-S746

2023

Volltextzugriff (PDF)

Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients

Annals of oncology, 2003-01, Vol.14 (suppl-1), p.i29-i36

2003

Volltextzugriff (PDF)

738P Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trial

Annals of oncology, 2022-09, Vol.33, p.S881

2022

Volltextzugriff (PDF)

1244P Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP)

Annals of oncology, 2020-09, Vol.31, p.S806-S807

2020

Volltextzugriff (PDF)

1442P DURATION: A multicenter randomized phase II trial investigating sequential mono- (mCTX) or doublet-chemotherapy (dCTX) followed by durvalumab (D) in older or frail patients with advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2023-10, Vol.34, p.S820-S820

2023

Volltextzugriff (PDF)

Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas

European journal of haematology, 2007-02, Vol.78 (2), p.93-101

2007

Volltextzugriff (PDF)

1021P DURATION - a phase II randomized trial in older / frail patients (pts) with advanced non-small cell lung cancer (NSCLC) comparing chemotherapy (CTX, 4 cycles) with CTX (2 cycles) and consecutive durvalumab (D): Top-line early efficacy endpoints

Annals of oncology, 2022-09, Vol.33, p.S1021-S1022

2022

Volltextzugriff (PDF)

Production and separation of positron emitters for hadron therapy at FRS-Cave M

Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms, 2023-08, Vol.541, p.114-116

2023

Volltextzugriff (PDF)

Occurrence of corneal microcystoid alterations under administration of belantamab mafodotin for multiple myeloma

Die Ophthalmologie, 2023-07, Vol.120 (7), p.747-750

2023

Volltextzugriff (PDF)

Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphoma

Journal of cancer research and clinical oncology, 2009-03, Vol.135 (3), p.459-466

2009

Volltextzugriff (PDF)

Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation

Leukemia, 2005-03, Vol.19 (3), p.490-492

2005

Volltextzugriff (PDF)

1508TiPDurvalumab in frail and elder patients with stage four NSCLC: The DURATION trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Serum Free Light Chain Analysis and Urine Immunofixation Electrophoresis in Patients with Multiple Myeloma

Clinical cancer research, 2005-12, Vol.11 (24), p.8706-8714

2005

Volltextzugriff (PDF)

WESTERN TOAD (ANAXYRUS BOREAS) BREEDING TIMING AND LARVAL DEVELOPMENT IN LAKE CUSHMAN RESERVOIR, WASHINGTON STATE

Northwestern naturalist (Olympia, Wash.), 2021-08, Vol.102 (2)

2021

Volltextzugriff (PDF)

Examining Intrinsic Motivations in Campus Intramural Sports

Recreational sports journal, 2012-04, Vol.36 (1), p.25-36

2012

Volltextzugriff (PDF)

6608 POSTER An expanded access clinical program of erlotinib in patients (pts) with advanced stage IIIb/ IV non-small-cell lung cancer (NSCLC) – an update of a single institution experience

European journal of cancer supplements, 2007, Vol.5 (4), p.390-390

2007

Volltextzugriff (PDF)

Experiment on space charge driven nonlinear resonance crossing in an ion synchrotron

Physical review special topics. PRST-AB. Accelerators and beams, 2010-11, Vol.13 (11), p.114203, Article 114203

2010

Volltextzugriff (PDF)

Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients

Journal of antimicrobial chemotherapy, 2006-01, Vol.57 (1), p.127-134

2006

Volltextzugriff (PDF)

Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience

Onkologie, 2008-01, Vol.31 (1-2), p.11-16

2008

Volltextzugriff (PDF)

AMPHIBIAN MOVEMENT ACROSS A NEW RESIDENTIAL ROAD IN WESTERN WASHINGTON STATE

Northwestern naturalist (Olympia, Wash.), 2019-12, Vol.100 (3), p.186

2019

Volltextzugriff (PDF)

The distribution of the wetwood of fir [Abies] in stem and root

Forstwissenschaftliches Centralblatt, 1981, Vol.100

Schuett P

1981

Volltextzugriff (PDF)

Open problems of forest pathology 100 years after Robert Hartig

Forstwissenschaftliches Centralblatt, 1979, Vol.98

Schuett P

1979

Volltextzugriff (PDF)

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(279)

Publikationsform

Sprache

Deutsch
(177)
Englisch
(165)

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(79)
Humans
(56)
Male
(36)
Female
(29)
Biological And Medical Sciences
(26)
Adult
(25)
Physical Sciences
(25)
Animals
(22)
Technology
(20)
Medical Sciences
(19)
Physics
(18)
Middle Aged
(16)
Forestry
(12)
Mice
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Medicine
(10)
Medicine & Public Health
(10)
Adolescent
(9)
Biochemistry & Molecular Biology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Durvalumab in frail and elder patients with stage four NSCLC: The DURATION trial

Focal species and landscape “naturalness” corridor models offer complementary approaches for connectivity conservation planning

1890P Switch-maintenance therapy with nivolumab in TKI-sensitive patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis for PD-L1 status of a randomized phase II study (NIVOSWITCH)

1293MO Safety and efficacy of hypo- and conventionally fractionated thoracic radiotherapy plus durvalumab in elderly or frail NSCLC stage III patients unfit for chemotherapy: Interim results from the TRADE-hypo trial

Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients

738P Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trial

1244P Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP)

1442P DURATION: A multicenter randomized phase II trial investigating sequential mono- (mCTX) or doublet-chemotherapy (dCTX) followed by durvalumab (D) in older or frail patients with advanced non-small cell lung cancer (NSCLC)

Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas

1021P DURATION - a phase II randomized trial in older / frail patients (pts) with advanced non-small cell lung cancer (NSCLC) comparing chemotherapy (CTX, 4 cycles) with CTX (2 cycles) and consecutive durvalumab (D): Top-line early efficacy endpoints

Production and separation of positron emitters for hadron therapy at FRS-Cave M

Occurrence of corneal microcystoid alterations under administration of belantamab mafodotin for multiple myeloma

Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphoma

Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation

1508TiPDurvalumab in frail and elder patients with stage four NSCLC: The DURATION trial

Serum Free Light Chain Analysis and Urine Immunofixation Electrophoresis in Patients with Multiple Myeloma

WESTERN TOAD (ANAXYRUS BOREAS) BREEDING TIMING AND LARVAL DEVELOPMENT IN LAKE CUSHMAN RESERVOIR, WASHINGTON STATE

Examining Intrinsic Motivations in Campus Intramural Sports

6608 POSTER An expanded access clinical program of erlotinib in patients (pts) with advanced stage IIIb/ IV non-small-cell lung cancer (NSCLC) – an update of a single institution experience

Experiment on space charge driven nonlinear resonance crossing in an ion synchrotron

Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients

Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience

AMPHIBIAN MOVEMENT ACROSS A NEW RESIDENTIAL ROAD IN WESTERN WASHINGTON STATE

The distribution of the wetwood of fir [Abies] in stem and root

Open problems of forest pathology 100 years after Robert Hartig

Suchergebnisse filtern